🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Harkaa Steatotic

Qorannoo klinikaalii Dhukkubaa Harkaa Steatotic Ameerikaa Keessatti hirmaatuu

Qorannoo 65 Dhukkubaa Harkaa Steatotic f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05832229

Early Tracking of Childhood Health Determinants (ETCHED) Study

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
1 Day – 99 Years · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03481829

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07165028

Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 5 hanga 16 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06133101

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221188

Fully Automated High-Throughput Quantitative MRI of the Liver

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05294471

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06419374

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT06354088

Quantifying Hepatic Mitochondrial Fluxes in Humans

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05305287

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05463796

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 25 hanga 55 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06993454

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT03884075

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06335771

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06571474

Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease

Namoota walitti qabaa jira
Umuriin 30 hanga 70 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07646197

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06613698

Fibrosis Lessens After Metabolic Surgery

Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06374875

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 18 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04634643

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.